Needham & Company downgraded Heron Therapeutics stock rating, while MarketBeat provided average stock rating data.

The entities involved

• MarketBeat →

  American personal finance blog

  • MarketBeat reported consensus ratings and target prices for Deep Fission Inc., which received a strong-buy rating from Benchmark.Fri 23:44
  • Several financial firms, including Raymond James Financial and Truist Financial, issued multiple rating and price target updates on November 6, 2026.Fri 22:59
• Needham & Company →

  American independent investment bank and asset management firm

  • Needham & Company increased its target price on Stagwell, while MarketBeat provided consensus rating data.Fri 21:10
  • Needham & Company lowered its price objective on Clearfield shares on November 3, 2026.Tue 20:19

Related events

• MarketBeat reported an average stock rating for Superior Group of Companies.Sep 17
• MarketBeat reported the stock's average rating as Benchmark and Jefferies reiterated buy ratings for Bright Minds Biosciences Inc.Fri 08:57
• MarketBeat provided average ratings and consensus target prices for Pacira BioSciences, while Needham and Royal Bank of Canada issued rating updates.Jul 1
• MarketBeat provided stock average ratings while Leerink Partners upgraded and Barclays raised its price objective for Summit Therapeutics.Wed 17:14
• MarketBeat reported average stock ratings while Jefferies Financial Group reiterated a buy rating for Sequoia Economic Infrastructure Inc.Jun 26